Chardan Analyst Lifts EyePoint Price Target to $65, Maintains Buy

Chardan analyst Andreas Argyrides significantly lifted the price target on EyePoint, Inc. (EYPT) to $65 from $29 on July 1, while maintaining a Buy rating. Argyrides described the company as "a de-risked, single-asset, catalyst-rich story" and one of the best get rich quick stocks to buy now.

Recommendation Change

Previously, the price target was $29 with a Buy rating. After the change, the new price target is $65, representing a 124% increase, with the Buy rating unchanged.

Analyst Rationale

The analyst believes EyePoint's single-asset pipeline is relatively low-risk and has multiple upcoming catalysts that could drive the stock higher. No further details were provided on the rationale behind the target hike.

Context

No other analyst recommendations were mentioned in the article. EyePoint's stock currently trades below the new target, suggesting potential upside if the analyst's expectations materialize.

What We Conclude

The price target increase reflects the analyst's optimism about EyePoint's prospects, but investors should consider the risk of a single-asset company. Further research is recommended before making investment decisions.